Prior to founding Ascletis, Dr. Wu was Vice President, global HIV Drug Discovery,
GlaxoSmithKline based on Research Triangle Park, NC, with responsibilities ranging
from target identification to clinical development.
Before joining GlaxoSmithKline, he was Vice President, Ambrilia Biopharma in Montreal.
He was directly responsible for the discovery and development of multiple clinical-stage
drugs at Ambrilia.
During his 18 years drug discovery and development career, he also held senior management
positions with increasing responsibilities at Immunex/Amgen, Novartis and Aventis.
He received his PhD in Cancer Biology from University of Arizona, Tucson, Arizona,
A member of China National “Thousand Talent Program” .
The Recruitment Program of Global Experts (also known as the Thousand Talents Plan)
was initiated by the General Office of the CPC Central Committee in December 2008.
It is the intention of the Plan to attract thousands of foreign experts, or returning-Chinese
talent, in the next 5 to 10 years to work in China and promote innovation and technological
development primarily in the high-tech and financial industries. The Plan involves
more than 10 state-level ministries and commissions and receives the most preferential
treatment from all levels of government. More information is available at http://www.1000plan.org